Cuba is set to begin clinical trials for Heberferon, a biotech drug for patients suffering from kidney and brain cancer, an expert from Cuba’s Center for Genetic Engineering and Biotechnology (CIGB) announced on Wednesday. Iraldo Bello, a biological sciences doctor, said the trials would be undertaken in 2017 and cover about 300 patients. Bello stressed […]
↧